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The Escherichia coli thymidine kinase/thymidylate kinase (tk/tmk) fusion gene encodes an enzyme that efficiently converts the prodrug
3V-azido-2V,3V-dideoxythymidine (AZT) into its toxic triphosphate derivative, a substance which stops DNA chain elongation. Integration of
this marker gene into vaccinia virus that normally is not inhibited by AZT allowed the establishment of a powerful selection procedure for
recombinant viruses. In contrast to the conventional vaccinia thymidine kinase (tk) selection that is performed in tk-negative cell lines, AZT
selection can be performed in normal (tk-positive) cell lines. The technique is especially useful for the generation of replication-deficient
vaccinia viruses and may also be used for gene knock-out studies of essential vaccinia genes.
Published by Elsevier Inc.Keywords: Dominant selection; Vaccinia virus; Thymidine kinase; Thymidylate kinase; Viral vectorsIntroduction
Vaccinia virus is a useful tool in biomedical research and
recombinant viruses are normally generated by homologous
recombination using a broad number of selection markers
(Moss, 1996). At present, the most frequently used
procedures are tk-negative selection by insertional inactiva-
tion of the endogenous vaccinia tk-gene (Mackett et al.,
1982) color screening using the Escherichia coli h-
galactosidase or h-glucuronidase genes (Carroll and Moss,
1995; Chakrabarti et al., 1985) and dominant positive
selection using the E. coli hypoxanthine-guanine phospho-
ribosyltransferase (gpt) marker gene (Boyle and Coupar,
1988; Falkner and Moss, 1988). Finally, rescue techniques
of functionally defective viruses are fast ways to obtain
replicating recombinants (Blasco and Moss, 1995; Holzer et
al., 1998). Defective vaccinia viruses growing only in
engineered complementing cell lines are particularly diffi-
cult to select and, in order to obtain marker-free viruses, are0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2005.04.009
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E-mail address: falknef@baxter.com (F.G. Falkner).usually purified by transient selection procedures requiring
6–8 rounds of plaque purification (Holzer and Falkner,
1997). Therefore, in order to more stringently select for
recombinant defective viruses, a dominant negative selec-
tion procedure is desirable. Moreover, a clear identification
of essential genes still depends on conditionally lethal
mutations (Condit et al., 1983; Ensinger, 1982) that can be
mapped to the respective locus. Therefore, the dominant
selection fusion marker gene tk/tmk, that is independent of
tk-negative cell lines, was studied to overcome these
restrictions.Results
The tk/tmk fusion gene inhibits growth of vaccinia in the
presence of AZT
Wild-type vaccinia virus replicating in a host cell cannot
be inhibited by AZT (Shneider et al., 1987), implying that
the endogenous vaccinia tk-gene and also the host cell
enzymes do not use the prodrug efficiently. In contrast, the
E. coli tk/tmk fusion gene efficiently converts AZT to AZT-05) 235 – 241
Fig. 2. Inhibition of the virus vtk-suci2 and of wild-type virus (VV-wt) by
AZT. In the absence of the drug (A, C) both viruses grow normally. In the
presence of AZT, wild-type vaccinia is not inhibited (B), while tk/tmk-
positive virus is totally suppressed.
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vaccinia recombinants in wild-type cells. In order to test this
assumption a recombinant virus was constructed containing
the tk/tmk Fsuicide_ gene under control of the vaccinia P7.5
early/late promoter. The insertion plasmid ptk-D4-suci, used
in the recombination experiment, directs the P7.5 tk/tmk
gene cassette into the vaccinia tk-gene inactivating it. The
resulting virus, obtained by rescue of a defective virus with
the D4R marker was termed vtk-suci2 (Fig. 1B) and is based
on the WR laboratory strain. This prototype virus was tested
together with the wild-type control virus in inhibition
experiments with the prodrug AZT in the monkey kidney
cell line CV-1. Without AZT, both viruses grew normally
(Figs. 2A, C). In the presence of the prodrug, however, the
tk/tmk expressing virus vtk-suci2 was strongly inhibited
(Fig. 2D), while the wild-type virus formed large plaques
(Fig. 2B) demonstrating proof-of-principle of vaccinia AZT
selection.
Determination of the minimal inhibitory dose of AZT
The prototype recombinant virus vtk-suci2 has the tk/tmk
fusion gene integrated into the vaccinia tk-locus. To prove
that the selection procedure does not interfere with vaccinia
tk activity and that also strains other than WR can be used,
an AZT-sensitive virus based on the Lister strain was
constructed, having the marker integrated in an intergenic
region (the region located between the D4R and the D5R
open reading frames) leaving the endogenous vaccinia tk
gene intact. The plasmid pDD4.4-suzi2, in which the tk/tmk
gene is located in the intergenic region downstream of D4R,
was used to construct this novel drug-sensitive vaccinia
recombinant. The virus was termed vsuci2-L (Fig. 1C).Fig. 1. Schematic representation of the viruses. The wild-type virus (VV-wt)
is shown in (A). The virus vtk-suci2 has the tk/tmk fusion gene integrated in
the vaccinia tk-locus (B). In the virus vsuci2-L (C), the suicide gene is
inserted in the intergenic region of ORFs D4R and D5R. The virus vtk-Z
has the lacZ gene integrated into the vaccinia tk-locus (D). The virus eVAC-
1 is a defective having the D4R gene deleted (E).We next performed more detailed studies on the
minimal inhibiting prodrug dose using the two tk/tmk-
positive viruses vtk-suci2 and vsuci2-L and three control
viruses, vtk-Z, eVAC-1 and wild-type vaccinia (for genetic
structures see Fig. 1; for genotypes see Table 1). The four
viruses were titered at different concentrations of AZT in
CV-1 cells and also in the rabbit kidney cell line RK44.20
used for complementation of defective viruses (Table 1).
Six well plates of cells were infected with 50 pfu/well of
the indicated viruses and were then incubated at increasing
AZT concentrations. Plaques were visualized 3 days after
infection by crystal violet staining. The tk/tmk expressing
viruses could be completely inhibited at AZT concen-
trations >0.25 mg/ml in CV-1 cells. Viruses without the tk/
tmk gene formed clearly visible plaques up to 1 mg/ml
AZT. However, a gradual reduction in plaque size and
number was observed, being detectable at 0.5 mg/ml of the
prodrug. The AZT sensitivity of eVAC-1, a defective virus
bearing no suicide gene, was also tested. Plaques were still
detectable at 1 mg/ml of the drug although at moderately
reduced size. The toxic effect on CV-1 and RK44.20 cells
was observed at AZT concentrations >1.5 mg/ml. The
vaccinia tk-gene had no inhibiting effects on virus growth
in the presence of AZT. However, double tk-positive
viruses (vsuci2-L) were slightly more sensitive to AZT
inhibition (Table 1). As a conclusion, a concentration of
0.5 mg/ml AZT suppressed all types of suicide gene
bearing viruses, without significant interference with
recombinants that are lacking the marker. The only
exception was the virus vtk-suci2 grown in RK44.20 cells,
which needed 0.75 mg/ml for full inhibition. The dose of
0.75 mg/ml was therefore used in the following selection
experiments.
Table 1
Inhibition of VV recombinants by AZT
Virus Genotype Vaccinia strain Cell line % growth at AZT concentration (mg/ml)
Suci VVtk 0 0.25 0.5 0.75 1.0
vsuci2-L + + Lister CV1 100 – – – –
VV Wt  + Lister CV1 100 100 100 100* 80*
vtk-suci2 +  WR CV1 100 –** –** – –
vtk-Z   WR CV1 100 100 90 30* –**
vsuci2-L + + Lister 44.20 100 –** – – –
VV Wt  + Lister 44.20 100 100 100 90* 50*
vtk-suci2 +  WR 44.20 100 50 20* –** –
vtk-Z   WR 44.20 100 100 100* 100* 100*
evac-1  + WR 44.20 100 100 100 100 100
– , total inhibition.
* Plaques 50% of normal size.
** Minute lesions detectable.
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selection
Based on the inhibition studies, a new selection protocol
using a pre-made tk/tmk positive virus, a recombination
plasmid and AZT was outlined (Fig. 3). To construct a
desired recombinant virus, the tk/tmk marker is substituted
by the gene of interest (transgene, TG) by homologous
recombination using a recombination plasmid having
homologous flanking regions (in this example D3R and
D5R sequences). Since in the initial selection round with
AZT most recombinant viruses were killed by the by-
stander effect (not shown), a positive first selection step
preceding the negative selection is required (Fig. 3, positive
selection). This step is performed using the gpt and,
optionally, the h-galactosidase marker located betweenFig. 3. Schematic representation of selecting defective viruses. The parental
replicating AZT-sensitive virus has the marker gene inserted in an
intergenic region (in this example between ORFs D4R and D5R).
Homologous recombination with an insertion plasmid carrying the trans-
gene (TG) and a gpt/lacZ (gptZ) marker flanked by sequences of the D3R
and the D5R ORF results, using the positive and negative selection steps, in
the rapid generation of defective viruses having the essential gene D4R
deleted. If the marker gene is flanked by direct repeats, the finally obtained
virus is marker-free.short repeats. The gpt- and h-galactosidase positive plaques
are selected and purified for a second round. Then, the
plaques are purified twice in the presence of AZT. Since
located between repeats, the gpt/lacZ marker gene is lost as
soon as the gpt selective agents are removed (Fig. 3, step 2).
During AZT selection, the tk/tmk marker gene together with
the adjacent vaccinia gene are deleted according to the
architecture of the recombination plasmid. The so enforced
loss of an essential viral function is provided by the
appropriate complementing cell line. By this strategy,
defective viruses are more rapidly obtained while parental
virus or intermediate forms that still contain the tk/tmk gene
are actively killed.
To prove this protocol, the empirically difficult selection
of a defective virus (with transgene integration between the
D3R and D5R genes deleting D4R) based on the more
attenuated vaccinia strain Lister was attempted. For this
purpose, the virus vsuci2-L that carries the suicide gene in
the D4/D5 intergenic region, and the plasmid was pDW-
mH5-hTrp2 (in which the transgene and the gpt/lacZ marker
are located between ORFs D3R and D5R) were delivered
into the complementing host cells. The transgene in the
plasmid is an expression cassette for the melanocyte
differentiation antigen TRP-2 (human tyrosinase-related
protein 2) (Bouchard et al., 1994) the adjacent gpt/lacZ
marker cassette is flanked by repeats to allow for transient
selection. Infection and transfection steps were performed in
the complementing cell line RK44.20. As outlined above,
the recombinant viruses were identified by two rounds of
gpt selection including lacZ staining in RK44.20 cells. To
evaluate the efficiency of the negative selection procedure,
the plaque purifications were done in parallel with 0.75 mg/
ml AZT and without AZT selection. In the first AZT
selection steps, a markedly reduced plaque count was
observed, compared to total gpt-positive plaques. This
may reflect the inhibition of mixed plaques that cannot be
excluded by the positive selection procedure. After a total of
four rounds of plaque purification, only one wild-type free
isolate out of 12 examined was obtained by the positive gpt
selection protocol alone, whereas all 11 primary isolates
Fig. 4. Characterization of the recombinant viruses by Southern blotting.
DNA fragments of viral isolates was separated by agarose gel electro-
phoresis and blotted according to standard techniques. (A) Fragments were
hybridized to the tk/tmk probe (isolated as an NcoI –SalI fragment from
plasmid pDD4.4-suci2). The tk/tmk-positive parental virus vsuci2-L is the
only virus showing a signal (lane 13); no tk/tmk gene is present after AZT
selection. (B) Hybridization with the TRP2 gene probe (plasmid pPCR-
hTrp2) shows, that all but one isolate had the transgene integrated resulting
in the expected sized fragments.
Fig. 5. Components of the AZT selection system. The plasmid pDD4.4-
suci2 which contains the P7.5-tk/tmk gene cassette was used to construct
the virus vsuci2-L, the parental virus for insertions into an intergenic region
(D4/5 region) derived from the vaccinia Lister strain. The plasmid DRMa
may serve to take up foreign gene cassettes (the multiple cloning site, MCS,
has the unique restriction sites NotI, XhoI, HindIII) and is used to construct
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Since many rounds of plaque purification are required to
obtain a sufficient number of isolates of pure defective virus
(using the Lister strain as parental virus) without negative
selection pressure, dominant negative selection is a power-
ful tool to counterselect against replicating parental virus.
This counterselection actively kills residual tk/tmk positive
virus still present in recombinant virus stocks. Using
positive selection alone obviously requires more purification
steps.
The replacement of the suicide marker by the correctly
inserted gene of interest was demonstrated for the isolates
purified under AZT by Southern blotting using a tk/tmk and
a TRP-2 gene probe (Fig. 4). Ten of 11 virus isolates grown
in the complementing cell line RK44.20 had the expected
structure (lanes 2, 3, 5–12). One isolate did not contain the
foreign gene and also not the suicide gene (lane 4). Since
this isolate did not grow in CV-1 cells, it is an illegitimate
defective recombinant virus and not a contaminating
parental virus. As expected, the Lister wild-type virus did
not react with both gene probes (lane 14), whereas the
parental virus vsuci2-L showed the correct 3.0 kb signal
with the tk/tmk probe but not with the foreign gene (Trp2)
probe (lane 13). The blot was negative for a gpt/lacZ probe
(not shown). The results therefore confirm the structures of
the recombinants and validate the selection procedure.
The components and the application of the system are
summarized in Fig. 5. The plasmid used to construct the
virus vsuci2-L, pDD4.4-suci2, may also serve as the source
of the p7.5-tk/tmk gene cassette. The plasmids pDRMa
(Ober et al., 2002) can be used to insert foreign gene
cassettes into the multiple cloning site (MCS) and further to
construct replicating recombinants together with the paren-
tal virus vsuci2-L (or similar vectors based on other vaccinia
strains) by AZT selection. Plasmids such as pDW (Holzer et
al., 1998) allow the construction of marker-free defective
viruses by the new procedure.
Mutation rate of BudR versus AZT
High frequencies of tk-negative point mutants (20–90%,
sometimes more) are a known to occur with classical
vaccinia tk-negative selection in recombination experiments
requiring the use of an additional positive selection or
screening step. Usually, between 10 and 80% of tk-negative
plaques are formed by recombinants, although the percent-
age may be significantly lower (Chakrabarti et al., 1985). A
high frequency of reversions would also prevent the use of
the AZT selection procedure as a tool to characterizeTable 2
Plaque purifications of isolates on CV-1 and RK44.20 cells
Method Round 1 Round 2 Round 3 Round 4
gpt/color screening 0/12a 0/12 1/12 1/12
AZT-negative selection 0/11 2/11 11/11 11/11
a Ratio of pure isolates (growing only in RK44.20 cells)/total isolates.
replicating recombinant viruses. The multiple cloning site of the plasmid
pDW has the unique restriction sites SmaI, NotI, XhoI, HindIII for insertion
of genes; the plasmid may be used to construct defective recombinants
without marker genes. P7.5, vaccinia promoter driving the 7.5-kDa gene;
tk/tmk, fusion gene consisting of the E. coli genes thymidine kinase and
thymidylate kinase; D3R, D4R, D5R, vaccinia open reading frames; gpt, E.
coli gene encoding hypoxanthine-guanine phosphoribosyltransferase; Z, E.
coli h-galactosidase gene.
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rate of tk/tmk expressing viruses. In inhibition experiments,
10,000 pfu of drug-sensitive virus, plated under AZT onto
two Roux bottles, did not result in visible escape mutants
suggesting reversion rates <1:104. Spiking experiments with
100 pfu wild-type virus per flask done in parallel showed that
tk/tmk-negative virus can be detected in the presence of
drug-sensitive virus under the chosen experimental condi-
tions. Using higher infectivities per cell of drug-sensitive
virus did not permit the detection of spiked wild-type viruses.
In order to further address the question of the mutagenic
potentials of BudR and AZT, five typical isolates of wild-
type and of tk/tmk virus were isolated and then titered with
and without selective pressure. First, both the wt and tk/tmk
viruses were plated out on CV-1 cells without selection, five
typical plaques of each parent were picked and grown to
small lysates. The titers of the WR wt lysates (obtained from
one 175 cm2 Roux bottle) were in the range of 0.32–4.8 
108 pfu/ml and the ones obtained from the vSuzi2-L virus in
the range of 2–9  107 pfu/ml (Table 3), reflecting the
better growth of WR wild-type compared the Lister
recombinant virus. Each of these lysates were now grown
in the presence of selection, the WR plaques under BudR in
tk-negative 143B cells and the tk/tmk plaques under AZT in
standard CV-1 cells.
In case of BudR selection, cells were infected at a MOI
of 0.05 pfu/cell and the lysates were grown and selected in
175 cm2 flasks to increase the detection limits. As shown in
Table 3, the mutation rate of wild-type virus in 143B cells
under BudR was in the expected range of 1: 1.6–7.7  104
pfu. Despite background cpe, the mutant plaques were
clearly visible. Unfortunately, in case of AZT selection (0.75
mg/ml) in CV-1 cells (infected with a MOI of 0.05 pfu/cell)
mutants could not be identified unambiguously. At the same
MOI (0.05 pfu/cell) or even at a lower one (0.01 pfu/cell),
background cpe and the previously observed bystander
killing prevented good plaque formation of spiked wild-type
virus and therefore did not allow clear identification ofTable 3
Estimation of mutation rates of vaccinia clones in tk-negative 143B cells
after BrdU selection and in CV-1 cells after AZT selection
Virus clone Titer of lysate
(108 pfu/ml)
Number of
mutants
Mutation
rate (104)a
WR#1 1.0 48 2.1
WR#2 4.8 31 3.2
WR#3 1.5 33 3.0
WR#4 2.1 62 1.6
WR#5 0.32 13 7.7
vSuzi2#1 0.66 – –b
vSuzi2#2 0.90 – –
vSuzi2#3 0.50 – –
vSuzi2#4 0.22 – –
vSuzi2#5 0.45 – –
a 143B cells were infected at a MOI of 0.05 and CV-1 cells at MOIs‘ of
0.05 and 0.01.
b Mutation rates could not be determined due to background cpe and/or
bystander killing.tk/tmk negative mutants. A higher AZT concentration of
1.25 mg/ml reduced background cpe but also prevented
plaque formation of the wild-type spike virus. Therefore, a
precise mutation rate could not be determined for the AZT
selection procedure by the chosen procedures.
Identification of essential genes by AZT selection
Vaccinia genomes encode approximately 200 genes,
many of which are still uncharacterized. Gene knock-out
experiments may further identify a gene as essential,
however, attempts to delete or substitute an essential gene
by recombination techniques usually fail because potent
counterselection procedures are not available. In a model
experiment, we therefore attempted to co-delete the known
essential D4R open reading frame (Upton et al., 1993)
together with the tk/tmk suicide gene. For this experiment,
we performed the same recombination as described above
using the plasmid pDW-mH5-hTrp2, however, using non-
complementing CV-1 cells in all steps. Twelve plaques that
were isolated under gpt selection/lacZ screening were
purified a second time either by gpt/lacZ or by AZT
selection. Clearly visible large plaques were obtained by
gpt/lacZ selection, indicating a mixed phenotype with helper
viruses. When gpt/lacZ-positive plaques from round 1 were
further selected with AZT, only minor lesions with weak
lacZ expression were visible (data not shown). The material
from these lesions could not be propagated in a subsequent
round of selection in CV-1 cells indicating that co-deletion
of the essential gene together with a dominant negative
marker was not possible. Co-deletion experiments combin-
ing the positive gpt/lacZ procedure followed by negative
AZT-selection may therefore be used as a tool to discern
essential from nonessential vaccinia genes.Discussion
It is usually easy to obtain recombinant viruses with the
Western Reserve strain because of the large plaques this
strain induces in many host cell lines. Recombinants with
more attenuated vaccine strains (such as Lister or MVA) are
more difficult to construct and therefore need improved
selection systems. With the AZT selection method, an
efficient negative selection protocol could now be estab-
lished even for vaccinia recombinants that are otherwise
difficult to isolate and where classical vaccinia tk selection
is not possible. The novel E. coli tk/tmk fusion gene
provides stringent selection allowing isolation of recombi-
nants starting with a tk/tmk-positive parental virus. The fact
that a marker gene containing parental virus has to be
initially constructed limits the usefulness of the method.
However, for the generation of vaccinia Lister recombi-
nants, the virus vsuci-L is now available as parental virus
enabling negative counterselection with AZT together with
the recombination plasmids pDRMa for the construction of
G.W. Holzer et al. / Virology 337 (2005) 235–241240replicating viruses or the plasmid pDW for defective
recombinant viruses. In addition, since the positive selection
step is performed with the transient gpt/lacZ marker gene,
the procedure results in a marker-free recombinant virus by
a series of simple plaque purification steps. The procedure is
particularly useful for the rapid construction of defective
viruses reducing the numbers of plaque purifications
substantially and should be considered as further selection
principle when complex vaccinia recombinants with multi-
ple inserts are constructed.
Further, in a model knock-out experiment with a known
essential gene, the E. coli tk/tmk fusion gene served as a
tool for the characterization of an essential viral open
reading frame. Due to the empirically apparent low
spontaneous reversion to the wild-type (AZT resistant)
phenotype, the marker provides sufficient selection pressure
to make a decisive statement on the role of the gene to be
deleted. Thus, this fusion marker gene is the basis for a
stringent negative selection procedure for vaccinia recombi-
nants in a standard cell line and may also be a useful marker
gene in other viral systems, such as herpes viruses.Materials and methods
Viruses and cell lines
The African green monkey kidney cell line CV-1 (ATCC
CCL-70), the vaccinia virus strains Western Reserve (WR;
ATCC VR119) and Lister/Elstree (ATCC VR-862) were
obtained from the American Type Culture Collection. The
cell line RK44.20 and the defective vaccinia virus eVAC-1
are described elsewhere (Holzer and Falkner, 1997; Holzer
et al., 1998).
Selective media
AZT was purchased from Invivogen Inc, CA. For dose
finding studies, infections were done in DMEM (Gibco/
BRL), 10% fetal calf serum, containing the indicated
concentration of the selective agent. Since the inhibitory
potential of AZT is cell line dependent and seems to vary
from batch to batch it is recommended to determine the
inhibitory dose with each new batch of AZT. For plaque
purifications, DMEM/1% low gelling agarose overlays with
the drug were prepared.
Construction of plasmids and viruses
ptk-D4-suci and vtk-suci2
The tk/tmk fusion gene was PCR-amplified from the
plasmid pGT63-LacZ (Invivogen Inc, CA) using the primers
o-mut-tdk-1 5V-GTC CTT GCC ACC ATG GCA CAG CTA
TAT TTC-3V and 5V-CGG GCC GCG TCG GAA GCT TAC
GCG TCC AAC TCC-3V and placed under control of the
vaccinia promoter P7.5. This expression cassette was clonedbetween sequences of the vaccinia tk-locus for homologous
recombination together with the vaccinia D4R gene as a
rescue marker. Twenty micrograms of plasmid ptk-D4-suci
were transfected into CV-1 cells infected with the defective
virus eVAC-1 and recombinants were obtained by rescue
with the D4R marker (Holzer et al., 1998). The replicating
tk-negative virus vtk-Z has been described previously
(Holzer et al., 1999).
pDD4.4-suzi2 and v-suci2-L
The tk/tmk fusion gene was excised from the plasmid
pGT63-lacZ as a NcoI/HindIII fragment and inserted into
NcoI/HindIII digested plasmid pDD4-P7.5, a derivative of
pER (Holzer et al., 1998), which contains the P7.5 promoter
followed by a multiple cloning site in the intergenic region
between the vaccinia D4R and D5R genes. It was used for
the construction of the virus v-suci2-L, pDD4.4-suzi2 was
transfected into CV1 cells previously infected with the
defective parental virus dVV-L according to standard
procedures (the defective virus dVV-L is based on the
Lister strain and the D4R gene is deleted (Ober et al., 2002).
Plaques were purified in three passages in CV1 cells. During
these plaque purifications, the recombinant v-suci2-L
isolates are selected by their ability to grow normally, while
the parental defective virus cannot propagate outside the
complementing RK44 cell line. After three rounds of plaque
purification, the isolates were grown to large scale, curde
stocks were prepared. Crude stocks were titered in the
absence of AZT and tested for inhibition in the presence of
AZT (1.25 mg/ml) to verify the purity of the isolate.
pDW-mH5-hTrp2
The human tyrosinase-related protein 2 (TRP-2) coding
sequence was PCR amplified from a human melanoma
cDNA library (Clontech cat. #7440-1) with the oligonu-
cleotides 5V-ATC ATG AGC CCC CTT TGG TGG-3V and
5V-CAA TTG TTA ACC CTA GGC TTC TTC TGT GTA
TC-3V as primers. The Trp2 cDNAwas placed under control
of the modified VV H5 promoter mH5 (Wyatt et al., 1996)
and inserted into the multiple cloning site of the plasmid
pDW-2, a derivative of pDW with more cloning sites
(Holzer et al., 1998).Acknowledgments
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